Now In Korea
Indie K-Beauty Brand Medicube Reaches ₩1 Trillion; APR Eyes ₩2 Trillion Revenue
Creatrip Team
a month ago
South Korea’s indie skincare brand Medicube, under APR, became the first independent K-beauty label to surpass annual sales of ₩1 trillion (about $? ) as the company recorded record results. APR’s cosmetics and device divisions together posted strong growth—cosmetics and beauty sales rose 218.2% to ₩1.0771 trillion and devices climbed 131.2% to ₩407 billion—helping APR achieve total revenue of ₩1.5273 trillion and operating profit of ₩365.4 billion. Medicube alone generated ₩1.4841 trillion, more than double the previous year.
Analysts credit a “beauty-tech” ecosystem that pairs skincare products with beauty devices for driving demand: Medicube’s AgeR device reached 6 million cumulative sales, expanding consumer touchpoints and boosting high-performance skincare purchases. Global demand also surged—several Medicube products ranked among Amazon bestsellers during Black Friday—and offline entry via Ulta Beauty (Ulta, a major U.S. retailer) increased U.S. revenue share from 22% to 37%. APR’s overseas sales rose to 80% of total, with U.S. and Japan revenue jumping sharply.
Industry observers say Medicube’s milestone challenges the dominance of conglomerate-owned K-beauty brands and signals a shift toward product efficacy and global competitiveness. APR plans to keep expanding globally with new products and stronger on-/offline channels, with the company viewed as a contender to reach ₩2 trillion in sales this year.
Like the information?